Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Four ultrasound devices added to third-party review program via FDA final guidance.

This article was originally published in The Gray Sheet

Executive Summary

FDA FINAL 510(k) GUIDANCE ON ULTRASOUND SYSTEMS AND TRANSDUCERS brings to 27 the number of Class II devices eligible for outside scrutiny under the agency's third-party 510(k) review pilot. Although the guidance applies to all ultrasound equipment, the agency's Sept. 30 release of the final version permits FDA to add four specific Class II ultrasound devices to the third-party review program: nonfetal ultrasonic monitors, ultrasonic pulsed doppler imaging systems, ultrasonic pulsed echo imaging systems, and diagnostic ultrasonic transducers.



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts